Fig. 4From: Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver diseaseThe effect of MCS on type 2 diabetes patients with NAFLD model rat. a content of serum FBG and FINS, b level of serum TG and TC, c activities of serum ALT, AST and GGTBack to article page
